Pré-Programme

 

Keynote lecture:

 

Shai Izraeli (University of Tel-Aviv, Israel)

JAK-STAT driven "Ph-like" ALL - what biology may teach us about therapy

 

Oratrices/orateurs confirmé(e)s

​

Raphael Itzykson (Department of Hematology and Immunology, Hopital Saint-Louis, AP-HP & Université de Paris, INSERM UMR944 Saint-Louis Research Institute, Paris)

Clinical Relevance of Clonal Architecture in Leukemias

 

Els Verhoeyen (Université Côte d’Azur, C3M, Equipe ‘Cancer et metabolism’ – NICE

et International center for research in infectiology CIRI – EVIR, Lyon)

GAPDH over-expression in the T cell lineage leads to a rare T cell lymphoma through a NF-κB dependent mechanism 

 

Isidro Sánchez-García (Instituto de Biología Molecular y Celular del Cáncer-IBMCC (CSIC-USAL). Salamanca, Spain)

A consensus model for the causation of childhood B cell precursor ALL

 

Julien Bertrand (Université de Genève, Suisse)

How to expand HSCs: a tale of zebrafish tails

 

Adam J Mead (Radcliffe Department of Medicine, Oxford, England)

Title to be announced

 

Elodie Segura (INSERM U932, Institut Curie, Paris)

Mechanisms of monocyte differentiation in steady-state and inflammation.

 

Elisa Laurenti (Wellcome - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, England)

Functional and molecular diversity of the human haematopoietic stem cell compartment

 

Michaela Fontenay (Institut Cochin, Paris)

A novel role for splicing factor SF3B1 in the control of DNA replication in erythropoiesis: the lessons of myelodysplastic syndromes with ring sideroblasts.

 

Claire Francastel (Université de Paris Diderot, Paris)

DNA methylation and disease: perspectives from the study of rare genetic disorders

 

Session « jeunes recruté.e.s aux concours des chercheurs de la Recherche Publique»

 

En cours de préparation